Challenge
A listed North American company needed hands-on support with the identification, assessment and in-licensing of early-stage oncology assets.
Solution
We consulted our industry network to identify a number of high-quality opportunities that had not yet been identified by our client’s in-house business development team. We worked closely with our client’s scientific staff to screen and assess opportunities prior to entering heads of terms, then provided advice on structuring heads of terms, subsequent due diligence and license negotiations.